Glenn Berry’s Post

Cordis ExoSeal EX700 Vascular Closure Device-7 Fr Part # EX700                   Exp 2/23, 5/21 The Cordis ExoSeal EX700 Vascular Closure Device is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5F, 6F, or 7F vascular sheath introducer with up

Cordis ExoSeal EX700 Vascular Closure Device-7 Fr Part # EX700                   Exp 2/23, 5/21 The Cordis ExoSeal EX700 Vascular Closure Device is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5F, 6F, or 7F vascular sheath introducer with up

Cordis ExoSeal EX700 Vascular Closure Device-7 Fr Part # EX700                   Exp 2/23, 5/21 The Cordis ExoSeal EX700 Vascular Closure Device is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5F, 6F, or 7F vascular sheath introducer with up

🫀Difference between pre dilatation vs post dilatation Catheter and their application 👉Pre-dilatation and post-dilatation catheters are both used in the context of percutaneous transluminal coronary angioplasty (PTCA) or balloon angioplasty procedures, primarily in the treatment of coronary artery disease. Here's the difference between the two and their applications: 👉Pre-dilatation Catheter: This type of catheter is used initially to dilate the narrowed coronary artery before deploying the stent. Pre-dilatation helps to prepare the lesion by expanding the narrowed segment and facilitating stent delivery. It can be particularly useful in cases where the lesion is highly calcified or has a complex morphology that may make stent deployment difficult without prior dilation. 👉Post-dilatation Catheter: 🌱Post-dilatation catheters are used after stent deployment to optimize stent expansion and apposition to the vessel wall. They are employed to further dilate the stent and ensure its proper positioning, shape, and adherence to the vessel wall. Post-dilatation is essential for improving stent outcomes, reducing the risk of stent thrombosis, and minimizing the potential for restenosis. Applications: 🌱Pre-dilatation catheters are used at the beginning of the PTCA procedure to prepare the lesion for stent deployment. They help to ensure adequate vessel preparation and facilitate successful stent placement. 🌱Post-dilatation catheters are used after stent deployment to optimize stent expansion and ensure proper apposition to the vessel wall. This step is crucial for achieving optimal procedural outcomes and reducing the risk of complications such as restenosis or stent thrombosis. In summary, while pre-dilatation catheters are used to prepare the lesion before stent deployment, post-dilatation catheters are employed after stent placement to optimize stent expansion and apposition. Both types of catheters play essential roles in the success of PTCA procedures and the long-term efficacy of coronary interventions. #medicaldevices #coronaryarterydisease #coronaryintervention #PTCAcatheters #Predilatationcatheters #Postdilatationcatheters

Retinal injections are a common treatment for various eye conditions. These injections deliver medication directly to the retina. This helps in treating diseases that affect the back of the eye like - Age-related macular degeneration (AMD) - Diabetic retinopathy - Retinal vein occlusion These conditions can lead to vision loss if not treated. Retinal injections help by reducing inflammation, stopping abnormal blood vessel growth, and preventing further damage. Karan Sindhwani Gaurang Srivastava Kirti Kumar kul deep Yash Pal Abdul Malik Eye Zenith https://lnkd.in/g_sKnC28

Ophthopedia Update:Incidence of Blepharoptosis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections: We aimed to determine the incidence of blepharoptosis following intravitreal anti-vascular endothelial growth factor (VEGF) injections and compare the rates of blepharoptosis between patients injected with an eyelid speculum and those injected without a speculum. #Ophthalmology #Ophthotwitter #Scicomm

The commercial launch of XIPERE® (triamcinolone acetonide injectable suspension) in early 2022 was a pivotal moment in the #eyecare industry. #XIPERE became the first and only therapy available in the United States that utilizes the suprachoroidal space (SCS®) to treat patients suffering from #macularedema associated with uveitis, a form of eye inflammation characterized by the accumulation of fluid in part of the retina. Macular edema is the leading cause of visual impairment in cases with uveitis. At the time, the SCS was an untapped frontier in eye health, and the approval of XIPERE made it possible to provide targeted delivery and compartmentalization of medicine to the back of the eye. The recently published SCS core consensus guidelines support standardization of SCS injection technique, with the goal of optimizing #patientsafety and outcomes. These new guidelines can help #eyecareprofessionals use this novel approach to help their patients. The guidelines can be found at: https://lnkd.in/gz4eTxUA At @Bausch + Lomb we will continue to support this evolving #drugdelivery approach for serious #eyedisease.    XIPERE is the first and only treatment approved to treat uveitic macular edema via injection to SCS and demonstrated significant and sustained best-corrected visual acuity (BCVA) improvements in clinical trials. XIPERE is administered via the suprachoroidal space using the SCS Microinjector®. The SCS Microinjector offers unprecedented access to the back of the eye where sight-threatening disease often occurs and provides targeted delivery to potentially improve efficacy and compartmentalization of medication. XIPERE is contraindicated in patients with active or suspected ocular or periocular infections and with known hypersensitivity to triamcinolone acetonide or any other components of this product. Use of corticosteroids may produce cataracts, increased intraocular pressure, and glaucoma. See additional Safety Information https://lnkd.in/gz7vRuCy) and full Prescribing Information (https://lnkd.in/g_K_Gvrt) at https://www.xipere.com. #EyeHealth #Innovation #SeeBetterLiveBetter #Ophthalmology

How to improve the efficiency and the safety of real-time ultrasound-guided central venous catheterization in 2023: a narrative review

Ophthopedia Update:Endophthalmitis Following Anti-VEGF Intravitreal Injections with Aqueous Chlorhexidine vs. Povidone-Iodine as Ocular Antiseptics: To compare the rates and outcomes of endophthalmitis after intravitreal injections for patients pre-treated with 5% povidone-iodine (PI) and 0.05% chlorhexidine (CHX). #Ophthalmology #Retina #Ophthotwitter

This article highlights the importance of a comprehensive understanding of metabolic acidosis in critical care and anesthesia, including its assessment, causes, and management strategies. The main points are: 1- Explanation of metabolic acidosis using traditional (bicarbonate) and physiochemical (Stewart) approaches to acid-base disturbance. 2- Identification of causes of metabolic acidosis in acutely unwell patients 3- Systematic evaluation of metabolic acidosis using a combination of traditional and physiochemical approaches based on simple measurements and derived variables. 4- Recognition that the outcome of metabolic acidosis is influenced by the underlying cause, with certain causes associated with poor outcomes and others with good outcomes. 5- Emphasis on directing treatment of metabolic acidosis towards addressing the underlying condition rather than focusing solely on correcting the acidosis. #MetabolicAcidosis #CriticalCare #Anesthesia #HealthcareInsights